Maravai LifeSciences
MRVI
#5104
Rank
NZ$2.14 B
Marketcap
$8.51
Share price
-35.27%
Change (1 day)
-2.39%
Change (1 year)

P/E ratio for Maravai LifeSciences (MRVI)

P/E ratio as of November 2024 (TTM): 8.91

According to Maravai LifeSciences 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 8.91147. At the end of 2022 the company had a P/E ratio of 8.57.

P/E ratio history for Maravai LifeSciences from 2020 to 2023

PE ratio at the end of each year

Year P/E ratio Change
20228.57-68.1%
202126.924.77%
202021.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-9.38-205.22% Jersey
-1.24-113.91%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.1950-102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-2.69-130.23%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.